We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells.
- Authors
Ferrand, Nathalie; Fert, Aude; Morichon, Romain; Radosevic-Robin, Nina; Zaoui, Maurice; Sabbah, Michèle
- Abstract
Simple Summary: Breast cancer is the most frequent malignancy in women worldwide. Advanced breast cancer with distant organ metastases is considered incurable with currently available therapies. The vasculogenic mimicry (VM) process is associated with an invasive and metastatic cancer phenotype and a poor prognosis for human breast cancer patients. Our aim was to study the effect of WISP2, a matricellular protein, on VM. We found that WISP2 inhibits VM through inhibition of CYR61 protein expression and YAP-TAZ signaling. Our finding may open promising candidates for blocking VM in breast cancer. Vasculogenic mimicry (VM) formed by aggressive tumor cells to create vascular networks connected with the endothelial cells, plays an important role in breast cancer progression. WISP2 has been considered as a tumor suppressor protein; however, the relationship between WISP2 and VM formation remains unclear. We used the in vitro tube formation assay and in vivo immunohistochemical analysis in a mouse model, and human breast tumors were used to evaluate the effect of WISP2 on VM formation. Here we report that WISP2 acts as a potent inhibitor of VM formation in breast cancer. Enforced expression of WISP2 decreased network formation while knockdown of WISP2 increased VM. Mechanistically, WISP2 increased retention of oncogenic activators YAP/TAZ in cytoplasm, leading to decreased expression of the angiogenic factor CYR61. Studies using an in vivo mouse model and human breast tumors confirmed the in vitro cell lines data. In conclusion, our results indicate that WISP2 may play a critical role in VM and highlight the critical role of WISP2 as a tumor suppressor.
- Subjects
IN vitro studies; IN vivo studies; NEOVASCULARIZATION; ANIMAL experimentation; IMMUNOHISTOCHEMISTRY; CCN intercellular signaling proteins; GENE expression; TUMOR suppressor genes; CELL lines; BREAST tumors; ANIMALS; MICE
- Publication
Cancers, 2022, Vol 14, Issue 6, p1487
- ISSN
2072-6694
- Publication type
Article
- DOI
10.3390/cancers14061487